Hong Kong Stock Movement | CARsgen Therapeutics-B (02171.HK) Rises Over 3% in Afternoon Session; CT1190B Completes First Patient Infusion in China Phase I Registrational Clinical Trial

Zhito Finance APP has learned that CARsgen Therapeutics-B (02171.HK) rose more than 3% in the afternoon. As of press time, it was up 3.04%, at HK$12.53, with a turnover of HK$20.6322 million.